The Mediator trial is about to begin. The Paris prosecutor’s office requested the correctional referral of the Servier laboratory, manufacturer of the drug.
The trial of the Mediator case will be able to start. The justice rejected all the appeals brought by the Servier laboratory. This Wednesday, the Paris prosecutor’s office requested the correctional referral of Servier laboratories and the Medicines Agency. The main part of this scandal should therefore be tried in court.
The charges relate to the grounds of “aggravated deception, fraud, manslaughter and manslaughter, and influence peddling”. The prosecution is also asking for a trial for the National Medicines Safety Agency (ANSM) for “manslaughter and manslaughter”.
14 accused on the bench
In addition, ten other “legal persons” could be tried in this potential lawsuit. Most of these are companies belonging to Servier or revolving around this group.
Fourteen “natural persons” would also be brought before the courts. Among them, the former number two of the group, Jean-Philippe Seta, officials, prescribing doctors or a former senator, Marie-Thérèse Hermange (UMP), suspected of having drawn up a report of convenience to Servier in 2011.
From now on, it is up to the investigating judges to decide whether or not to bring this case to trial. At the same time, a compensation procedure with Oniam (National Office for Compensation for Medical Accidents) was launched.
Since the start of the investigation, in 2011, and the revelations on this anti-diabetic diverted as an appetite suppressant, at the origin of several hundred deaths (500 to 2,100 in the long term, according to estimates), the Servier laboratory has been increasing its remedies. to escape a trial. An attitude deemed “clearly delaying” by the Parisian examining magistrates, according to AFP.
This Wednesday, the Paris Court of Appeal rejected the last of these appeals. The laboratory had requested the annulment of the examination for “fraud” and “aggravated deception”.
.
